Literature DB >> 19723560

Functional differences between D(1) and D(5) revealed by high resolution imaging on live neurons.

M Kruusmägi1, S Kumar, S Zelenin, H Brismar, A Aperia, L Scott.   

Abstract

The interaction between the dopaminergic and glutamatergic systems governs normal behavior and is perturbed in many psychiatric disorders including schizophrenia. Hypofunction of the D1 family of receptors, to which the D(1) and D(5) subtypes belong, is a typical feature of schizophrenia. Here we have used confocal live cell imaging of neurons to examine the distinct roles of the D(1) and D(5) receptors in the intra-neuronal interaction with the glutamatergic system. Using fluorescently tagged D(1) or D(5) expressed in cultured striatal neurons, we show that both receptor subtypes are primarily transported via lateral diffusion in the dendritic tree. D(1) is to a much larger extent than D(5) expressed in spines. D(1) is primarily expressed in the head whereas D(5) is largely localized to the neck of the spine. Activation of N-methyl-D-aspartic acid (NMDA) receptors slowed the diffusion rate and increased the number of D(1) positive spines, while no effect on D(5) diffusion or spine localization could be observed. The observed differences between D(1) and D(5) can be attributed to structural differences in the C-terminus and its capacity to interact with NMDA receptors and PSD-95. Identification of a unique role of D(1) for the intra-neuronal interaction between the dopaminergic and glutamatergic systems will have implications for the development of more specific treatments in many neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723560     DOI: 10.1016/j.neuroscience.2009.08.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons.

Authors:  Csaba Vastagh; Fabrizio Gardoni; Vincenza Bagetta; Jennifer Stanic; Elisa Zianni; Carmen Giampà; Barbara Picconi; Paolo Calabresi; Monica Di Luca
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

2.  A noncanonical postsynaptic transport route for a GPCR belonging to the serotonin receptor family.

Authors:  Thomas Liebmann; Markus Kruusmägi; Nermin Sourial-Bassillious; Alexander Bondar; Per Svenningsson; Marc Flajolet; Paul Greengard; Lena Scott; Hjalmar Brismar; Anita Aperia
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

3.  Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.

Authors:  Jingping Zhang; Taixiang Saur; Angela N Duke; Seth G N Grant; Donna M Platt; James K Rowlett; Ole Isacson; Wei-Dong Yao
Journal:  J Neurogenet       Date:  2014-04-22       Impact factor: 1.250

Review 4.  Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases.

Authors:  Fabrizio Gardoni; Camilla Bellone
Journal:  Front Cell Neurosci       Date:  2015-03-02       Impact factor: 5.505

Review 5.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

6.  Characterization of the Functional Cross-Talk between Surface GABAA and Dopamine D5 Receptors.

Authors:  François Maingret; Laurent Groc
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.